ATE377427T1 - Verwendung des hepatozyten-wachstumsfaktors zur förderung der induktion der vaskulären differenzierung - Google Patents

Verwendung des hepatozyten-wachstumsfaktors zur förderung der induktion der vaskulären differenzierung

Info

Publication number
ATE377427T1
ATE377427T1 AT05720656T AT05720656T ATE377427T1 AT E377427 T1 ATE377427 T1 AT E377427T1 AT 05720656 T AT05720656 T AT 05720656T AT 05720656 T AT05720656 T AT 05720656T AT E377427 T1 ATE377427 T1 AT E377427T1
Authority
AT
Austria
Prior art keywords
growth factor
hepatocyte growth
induction
promote
vascular differentiation
Prior art date
Application number
AT05720656T
Other languages
English (en)
Inventor
Hiroshi Kubo
Kota Ishizawa
Hidetada Sasaki
Toshikazu Nakamura
Original Assignee
Tohoku Technoarch Co Ltd
Kringle Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tohoku Technoarch Co Ltd, Kringle Pharma Inc filed Critical Tohoku Technoarch Co Ltd
Application granted granted Critical
Publication of ATE377427T1 publication Critical patent/ATE377427T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1833Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT05720656T 2004-03-09 2005-03-07 Verwendung des hepatozyten-wachstumsfaktors zur förderung der induktion der vaskulären differenzierung ATE377427T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004066415 2004-03-09

Publications (1)

Publication Number Publication Date
ATE377427T1 true ATE377427T1 (de) 2007-11-15

Family

ID=34918334

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05720656T ATE377427T1 (de) 2004-03-09 2005-03-07 Verwendung des hepatozyten-wachstumsfaktors zur förderung der induktion der vaskulären differenzierung

Country Status (10)

Country Link
US (1) US20070142279A1 (de)
EP (1) EP1722811B1 (de)
JP (1) JP2007528365A (de)
CN (1) CN1929856B (de)
AT (1) ATE377427T1 (de)
CA (1) CA2557884C (de)
DE (1) DE602005003211T2 (de)
ES (1) ES2293553T3 (de)
HK (1) HK1094529A1 (de)
WO (1) WO2005084700A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007099711A1 (ja) * 2006-02-28 2007-09-07 Juntendo Educational Foundation 分化誘導剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837676A (en) * 1993-10-18 1998-11-17 Long Island Jewish Medical Center Use of scatter factor to enhance angiogenesis
IT1271088B (it) * 1994-11-24 1997-05-26 Dompe Spa Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche
JPH08231416A (ja) * 1995-02-24 1996-09-10 Mitsubishi Chem Corp 血栓症治療剤
ES2289795T3 (es) * 1997-12-03 2008-02-01 Nakamura, Toshikazu Preparacion para administracion intravenosa continua.
CA2339378A1 (en) * 1998-08-05 2000-02-17 Sumitomo Pharmaceuticals Co., Ltd. Preparations containing hepatocyte growth factor for treating ischemic diseases by intramuscular administration
EP1889633B1 (de) * 2000-06-27 2011-10-26 AnGes MG, Inc. Medizinische Zusammensetzungen zur Angiogenese-Therapie
EP1415663B1 (de) * 2001-07-18 2008-10-15 MedGEL Corporation Hgf-hydrogel-zubereitungen mit verzögerter freisetzung

Also Published As

Publication number Publication date
WO2005084700A1 (en) 2005-09-15
DE602005003211D1 (de) 2007-12-20
CN1929856B (zh) 2010-11-10
HK1094529A1 (en) 2007-04-04
CN1929856A (zh) 2007-03-14
CA2557884C (en) 2011-12-06
DE602005003211T2 (de) 2008-02-21
US20070142279A1 (en) 2007-06-21
EP1722811B1 (de) 2007-11-07
ES2293553T3 (es) 2008-03-16
JP2007528365A (ja) 2007-10-11
EP1722811A1 (de) 2006-11-22
CA2557884A1 (en) 2005-09-15

Similar Documents

Publication Publication Date Title
Fennema et al. Ectopic bone formation by aggregated mesenchymal stem cells from bone marrow and adipose tissue: a comparative study
Oryan et al. Platelet-rich plasma for bone healing and regeneration
Ahmed et al. Fibrin glues in combination with mesenchymal stem cells to develop a tissue-engineered cartilage substitute
Laschke et al. Vascularization in tissue engineering: angiogenesis versus inosculation
Moioli et al. Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues
Cuomo et al. Mesenchymal stem cell concentration and bone repair: potential pitfalls from bench to bedside
Wu et al. Effects of hyperbaric oxygen on proliferation and differentiation of osteoblasts from human alveolar bone
TW200633733A (en) Biomaterials for guided tissue regeneration and drug delivery
WO2001068811A3 (de) Verfahren zur in vitro-herstellung von dreidimensionalem, vitalem knorpel- oder knochengewebe und dessen verwendung als transplantationsmaterial
MX2009001323A (es) Aposito solido para tratar tejido herido.
NO20031999D0 (no) Ikke begrensede somatiske stamceller derivert fra humant navlestrengblod
WO2005000245A3 (en) Compositions and methods for increasing telomerase activity
Li et al. Autologous platelet-rich plasma promotes neurogenic differentiation of human adipose-derived stem cells in vitro
Shou et al. Enhancement of bone‐marrow‐derived mesenchymal stem cell angiogenic capacity by NPWT for a combinatorial therapy to promote wound healing with large defect
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
Oni et al. Transdermal delivery of adipocyte-derived stem cells using a fractional ablative laser
Creeper et al. Effect of autologous and allogenic platelet‐rich plasma on human gingival fibroblast function
Miramond et al. Osteoinduction of biphasic calcium phosphate scaffolds in a nude mouse model
AU8180001A (en) Human growth hormone to stimulate mobilization of pluripotent hematopoietic stemcells
JP2020506200A5 (de)
DK1405906T3 (da) Schwann-celler stammende fra stromale knoglemarvsceller
EA200900881A1 (ru) Ингаляционные лекарственные формы связанных с полимерами бифосфонатов и способы их применения
Levi et al. Stem cells: update and impact on craniofacial surgery
Boos et al. Autologous serum improves bone formation in a primary stable silica-embedded nanohydroxyapatite bone substitute in combination with mesenchymal stem cells and rhBMP-2 in the sheep model
ATE283714T1 (de) Preadipozyten enthaltende biomaterialien zur regeneration von weichgewebe

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties